Actelion Settles With Generics Over Access to Drug Samples
When does a branded drug maker have to turn over product samples to generic competitors? An antitrust battle between Actelion Pharmaceuticals and three of its generic rivals offered some clues, but the case settled Friday without providing a definitive answer.
This premium content is reserved for American Lawyer subscribers.
Continue reading by getting started with a subscription.
Already a subscriber? Log in now